The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Antitumor Agents. 217. Curcumin Analogues as Novel Androgen Receptor Antagonists with Potential as Anti-Prostate Cancer Agents
Abstract
A number of curcumin analogues were prepared and evaluated as potential androgen receptor antagonists against two human prostate cancer cell lines, PC-3 and DU-145, in the presence of androgen receptor (AR) and androgen receptor coactivator, ARA70. Compounds 4 [5-hydroxy-1,7-bis(3,4-dimethoxyphenyl)-1,4,6-heptatrien-3-one], 20 [5-hydroxy-1,7-bis[3-methoxy-4-(methoxycarbonylmethoxy)phenyl]-1,4,6-heptatrien-3-one], 22 [7-(4-hydroxy-3-methoxyphenyl)-4-[3-(4-hydroxy-3-methoxyphenyl)acryloyl]-5-oxohepta-4,6-dienoic acid ethyl ester], 23 [7-(4-hydroxy-3-methoxyphenyl)-4-[3-(4-hydroxy-3-methoxyphenyl)acryloyl]5-oxohepta-4,6-dienoic acid], and 39 [bis(3,4-dimethoxyphenyl)-1,3-propanedione] showed potent antiandrogenic activities and were superior to hydroxyflutamide, which is the currently available antiandrogen for the treatment of prostate cancer. Structure-activity relationship (SAR) studies indicated that the bis(3,4-dimethoxyphenyl) moieties, the conjugated beta-diketone moiety, and the intramolecular symmetry of the molecules seem to be important factors related to antiandrogenic activity. The data further suggest that the coplanarity of the beta-diketone moiety and the presence of a strong hydrogen bond donor group were also crucial for the antiandrogenic activity, which is consistent with previous SAR results for hydroxyflutamide analogues. When the pharmacophoric elements of dihydrotestosterone (DHT) and compound 4 are superposed, the resulting construct implies that the curcumin analogues may function as a 17alpha-substituted DHT. Compounds 4, 20, 22, 23, and 39 have been identified as a new class of antiandrogen agents, and these compounds or their new synthetic analogues could be developed into clinical trial candidates to control androgen receptor-mediated prostate cancer growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene regulation by steroid hormones
Beato, M. (1989) · Cell · doi:10.1016/0092-8674(89)90237-7 · Cited by 3,383
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1998) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.48.1.6 · Cited by 2,341
Anti-tumour and antioxidant activity of natural curcuminoids
Ruby, A. J., Kuttan, G., Dinesh Babu, K., Rajasekharan, K. N., & Kuttan, R. (1995) · Cancer Letters · doi:10.1016/0304-3835(95)03827-j · Cited by 1,067
Chang, C. S., Kokontis, J., & Liao, S. T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7211 · Cited by 519
Self-citationInvolvement of the β-diketone moiety in the antioxidative Mechanism of Tetrahydrocurcumin
Sugiyama, Y., Kawakishi, S., & Osawa, T. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(96)00302-4 · Cited by 385
Prostate Specific Antigen Decline after Antiandrogen Withdrawal: the Flutamide Withdrawal Syndrome
Kevin Kelly, W., & Scher, H. I. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)36163-3 · Cited by 349
Polychlorinated biphenyls as hormonally active structural analogues.
McKinney, J. D., & Waller, C. L. (1994) · Environmental Health Perspectives · doi:10.1289/ehp.94102290 · Cited by 306
Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
Singh, S., Gauthier, S., & Labrie, F. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375371 · Cited by 236
Experiments in the biosynthesis of curcumin
Roughley, P. J., & Whiting, D. A. (1973) · Journal of the Chemical Society, Perkin Transactions 1 · doi:10.1039/p19730002379 · Cited by 224
Miyamoto, H., Yeh, S., Wilding, G., & Chang, C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7379 · Cited by 203
Self-citation
Cited by
Curcumin: From ancient medicine to current clinical trials
Hatcher, H., Planalp, R., Cho, J., Torti, F. M., & Torti, S. V. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7452-4 · Cited by 1,843
CURCUMIN: THE INDIAN SOLID GOLD
Aggarwal, B. B., Sundaram, C., Malani, N., & Ichikawa, H. (2007) · ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY · doi:10.1007/978-0-387-46401-5_1 · Cited by 1,647
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature
Anand, P., Thomas, S. G., Kunnumakkara, A. B., Sundaram, C., Harikumar, K. B., Sung, B., Tharakan, S. T., Misra, K., Priyadarsini, I. K., Rajasekharan, K. N., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.008 · Cited by 1,205
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Fluorine in medicinal chemistry: A review of anti-cancer agents
Isanbor, C., & O’Hagan, D. (2006) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2006.01.011 · Cited by 1,120
A Review of Curcumin and Its Derivatives as Anticancer Agents
Tomeh, M. A., Hadianamrei, R., & Zhao, X. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051033 · Cited by 949
Curcumin: An Anti-Inflammatory Molecule from a Curry Spice on the Path to Cancer Treatment
Basnet, P., & Skalko-Basnet, N. (2011) · Molecules · doi:10.3390/molecules16064567 · Cited by 733
Natural product and natural product derived drugs in clinical trials
Butler, M. S., Robertson, A. A. B., & Cooper, M. A. (2014) · Nat. Prod. Rep. · doi:10.1039/c4np00064a · Cited by 602
Heger, M., van Golen, R. F., Broekgaarden, M., & Michel, M. C. (2014) · Pharmacological Reviews · doi:10.1124/pr.110.004044 · Cited by 576
Role of Curcumin in Cancer Therapy
Shishodia, S., Chaturvedi, M. M., & Aggarwal, B. B. (2007) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2007.04.001 · Cited by 413
Promotion of Bladder Cancer Development and Progression by Androgen Receptor Signals
Miyamoto, H., Yang, Z., Chen, Y.-T., Ishiguro, H., Uemura, H., Kubota, Y., Nagashima, Y., Chang, Y.-J., Hu, Y.-C., Tsai, M.-Y., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk113 · Cited by 401
Self-citationCurcumin for chemoprevention of colon cancer
Johnson, J. J., & Mukhtar, H. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.03.005 · Cited by 396
Improving the Solubility and Pharmacological Efficacy of Curcumin by Heat Treatment
Kurien, B. T., Singh, A., Matsumoto, H., & Scofield, R. H. (2007) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2007.064 · Cited by 350
Comparative Antioxidant Activities of Curcumin and Its Demethoxy and Hydrogenated Derivatives
Somparn, P., Phisalaphong, C., Nakornchai, S., Unchern, S., & Morales, N. P. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.74 · Cited by 348
Liang, G., Shao, L., Wang, Y., Zhao, C., Chu, Y., Xiao, J., Zhao, Y., Li, X., & Yang, S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.10.044 · Cited by 331
Curcumin is a potent DNA hypomethylation agent
Liu, Z., Xie, Z., Jones, W., Pavlovicz, R. E., Liu, S., Yu, J., Li, P.-K., Lin, J., Fuchs, J. R., Marcucci, G., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.12.041 · Cited by 330
Curcumin and its analogues: Potential anticancer agents
Agrawal, D. K., & Mishra, P. K. (2010) · Medicinal Research Reviews · doi:10.1002/med.20188 · Cited by 312
Anti-oxidant activities of curcumin and related enones
Weber, W. M., Hunsaker, L. A., Abcouwer, S. F., Deck, L. M., & Vander Jagt, D. L. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.03.035 · Cited by 292
Nanotechnology-Applied Curcumin for Different Diseases Therapy
Ghalandarlaki, N., Alizadeh, A. M., & Ashkani-Esfahani, S. (2014) · BioMed Research International · doi:10.1155/2014/394264 · Cited by 288
Salem, M., Rohani, S., & Gillies, E. R. (2014) · RSC Advances · doi:10.1039/c3ra46396f · Cited by 257
Arentz, S., Abbott, J. A., Smith, C. A., & Bensoussan, A. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-511 · Cited by 191
Metadata
- Authors
- Ohtsu, H., Xiao, Z., Ishida, J., Nagai, M., Wang, H.-K., Itokawa, H., Su, C.-Y., Shih, C., Chiang, T., Chang, E., Lee, Tsai, M.-Y., Chang, C., & Lee, K.-H.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-10-12
- Volume
- 45
- Issue
- 23
- Pages
- 5037-5042
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2100736039
- Cited by
- 266
- References
- 15
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.